1 July 2016

Pan Pacific clinches new funding

Robert Tyerman

New funding should allow Pan Pacific Aggregates to begin work at its Pumptown granite quarry

New funding should allow Pan Pacific Aggregates to begin work at its Pumptown granite quarry

Battle-scarred Pan Pacific Aggregates (PPA) has raised £540,000, is on track for another £500,000 and is scouting some distressed acquisitions.

Broker VSA Capital, whose boss William Voaden also heads British Columbia-based PPA, secured the first tranche at a barely visible 0.15p and was offered the second by retail brokers speculating that the fortunes of the bombed-out company were now on the turn. VSA says £300,000 is in the bag at 0.225p and sounds confident of taking that to £500,000.

Voaden argues that this financing leaves only one hurdle before the company can pursue its ambitions to quarry granite at Pumptown in the locality. That is a public meeting on 25 August at the town of Abbotsford, within whose jurisdiction Pumptown lies and where Voaden argues the local mayor’s support should win the day for PPA.

Floated on AIM at 80p four years ago, PPA shares collapsed from 91p in 2006 to 0.25p more recently after a remorseless series of mishaps. First, resistance from indigenous people put paid to the company’s original project in the region’s Schelt Peninsula and then Pumptown hit technical and infrastructure snags, political opposition and obstruction from its local partner.

The latest funding should allow PPA, which lost £3.3 million last year and recently reached a creditors’ agreement at nine cents in the dollar, to make a start with Pumptown and exploit a regional shortage of aggregate, provided the Abbotsford meeting goes well. Voaden says the company is also talking to liquidators about possibly taking over two over-borrowed local sand and gravel concerns, a deal that would require further funding from the market.

At the height of the company’s crisis, analysts argued it was worth either nothing or significantly more than its current value. That remains the case and the odds have improved.

26 AUGUST UPDATE HERE

Click here to follow Growth Company Investor on Twitter.

Tags: Fundraisings, Mergers & acquisitions, Penny shares

Cash Shells 2015

Published in September 2015 this annual research report provides a comprehensive overview of cash shells on the Main Market, AIM and PLUS landscape. Order your copy today

 

Superb investment toolkit for private investors

SharePad is the new web-based service from ShareScope. Easier to use and more powerful. Perfect for tablets, Macs and Windows PC. Covers ALL your investment requirements.

Growth Company Investor: free trial

Since 2008, our share tips outperformed the benchmark by 281%. Take a free trial and get access to our recommendations today. Start free trial now.

Directors' Pay on AIM 2015

The most comprehensive review of AIM directors' pay available, and this year includes a record sample of 1000+ AIM-quoted companies. The full report is available to order for £385 + VAT. Click here for more info

 

Latest small-cap and growth company news

Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.

Popular News

Latest News

Avingtrans returns cash and remains a Buy

Having turned most of its market cap into cash through the sale of its aerospace division, it’s no surprise that Avingtrans (AIM: AVG) has been a very defensive stock during the recent turmoil. We now have some more details on the return of cash to shareholders which was promised as part of the disposal.

Omega investing in growth

Omega Diagnostics results looked positive and highlighted the progress being made in getting important new products to market. The investment to support those efforts will depress profits this year; but the market seems willing to look through this with Omega being a rare stock to be trading above its pre-Brexit level.

Stadium hit by profit warning

Stadium Group shares have been hit by a profit warning. This is a particular blow given the company’s progress in repositioning itself into a higher quality, design-led business.

Verona raises £42m to fund drug trials 

Verona Pharma (AIM: VRP) has raised an impressive £42 million net of costs which will fund phase II trials for its RPL554 compound. This drug targets severe respiratory diseases, in particular the 65 million worldwide sufferers from COPD (chronic obstructive pulmonary disease).

Income attractions at Belvoir

It’s fair to say that buy-to-let landlords have been under George Osborne’s cosh. He’s introduced a raised stamp duty rate and withdrawn higher-rate tax relief. However, Belvoir Lettings has seen little change in the market as far as its core lettings agency business is concerned. Furthermore, the shares have responded positively to a major acquisition which makes Belvoir the largest UK lettings agent.

Wincanton keeps on trucking

Wincanton CEO Adrian Colman feels his company is now back on an even keel after a period of fire-fighting. Debt has been brought under control, the pension deficit is being addressed, and onerous leases and contracts have been dealt with. A return to the dividend list illustrates these positive changes and the fact that management can now fully focus on growing the business.

More News